JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.15275

Gregory M Marcus

引用次数: 0

Emergency Medicaid Spending for Undocumented Immigrants in the US 美国无证移民的紧急医疗补助支出

JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.18709

Patricia Mae G. Santos, Kelsey Chalmers, Lilia Cervantes, Benjamin D. Sommers

引用次数: 0

Reaching Individualized Optimal Oxygen Therapy in Mechanically Ventilated Patients. 机械通气患者实现个体化最佳氧疗。

JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.14077

Can Xu,Xinyu Nie,Dongjin Wang

引用次数: 0

Long-Term Continuous Monitoring of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting 冠状动脉搭桥术后新发心房颤动的长期持续监测

JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.14891

Florian E. M. Herrmann, Anders Jeppsson, Hristo Kirov, Efstratios I. Charitos, Dana Dacian, Jürgen Brömsen, Steffen Massberg, Sebastian Sadoni, Torsten Doenst, Gerd Juchem, Christian Hagl

{"title":"Long-Term Continuous Monitoring of New-Onset Atrial Fibrillation After Coronary Artery Bypass Grafting","authors":"Florian E. M. Herrmann, Anders Jeppsson, Hristo Kirov, Efstratios I. Charitos, Dana Dacian, Jürgen Brömsen, Steffen Massberg, Sebastian Sadoni, Torsten Doenst, Gerd Juchem, Christian Hagl","doi":"10.1001/jama.2025.14891","DOIUrl":"https://doi.org/10.1001/jama.2025.14891","url":null,"abstract":"ImportanceThe incidence and burden of new-onset atrial fibrillation (AF) after coronary artery bypass grafting (CABG) are not known. Nevertheless, North American guidelines state that it is reasonable to administer 60 days of oral anticoagulation to patients with new-onset AF after CABG, a moderate-strength recommendation (class 2a) based on evidence derived from nonrandomized clinical studies.ObjectiveTo test the hypothesis that the incidence of new-onset AF within the first year after CABG is higher than suggested in the current literature and to assess AF burden.Design, Setting, and ParticipantsA prospective, multicenter cohort study in 2 academic cardiac surgery centers in Germany that involved 198 patients with 3-vessel coronary artery disease or left main disease and no history of arrhythmias who received an insertable cardiac monitor during CABG for long-term continuous electrocardiographic monitoring. Patients were enrolled from November 2019 through November 2023 and were followed up for 1 year.ExposuresAtrial fibrillation detected within a year of continuous monitoring using insertable cardiac monitors implanted during CABG.Main Outcomes and MeasuresCumulative incidence of new-onset AF within a year of surgery. Secondary outcomes were AF burden and clinical outcomes.ResultsA total of 1217 patients were assessed, and 1008 were excluded. Of the 198 patients enrolled (173 male [87.4%]; 25 female [12.6%]; mean age, 66 [SD, 9] years), 95 patients developed new-onset AF within the first year after CABG (cumulative incidence, 48%; 95% CI, 41%-55%). The median AF burden during the first year was 0.07% (IQR, 0.02%-0.23%) or 370 minutes. The median AF burden on days 1 through 7 was 3.65% (IQR, 0.95%-9.09%); on days 8 through 30, 0.04% (IQR, 0%-1.21%); and on days 31 through 365, 0% (IQR, 0%-0.0003%), corresponding to 368, 13, and 0 minutes, respectively. After discharge, 3 patients had an AF episode longer than 24 hours.Conclusions and RelevanceAlthough the incidence of new-onset AF after CABG in this study was higher than previously reported, the AF burden in these patients was very low, especially after 30 days. The very low AF burden questions the current guideline recommendations that long-term oral anticoagulation should be considered in patients with new-onset AF after CABG.","PeriodicalId":518009,"journal":{"name":"JAMA","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reaching Individualized Optimal Oxygen Therapy in Mechanically Ventilated Patients-Reply. 机械通气患者实现个体化最佳氧疗-回复。

JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.14080

Michael Grocott,Paul Mouncey,Daniel S Martin

引用次数: 0

Through the Glass 透过玻璃

JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.18165

Janki Shah

引用次数: 0

What Will Next Year Bring for AI in Health? 人工智能在健康领域将带来什么？

JAMA Pub Date : 2025-10-09 DOI: 10.1001/jama.2025.18529

Roy Perlis